Autologous Fat Grafting in Radiated Soft Tissue Reconstruction
A Pilot Study Treating Radiation Injury With Autologous Fat Transfer
1 other identifier
observational
10
1 country
1
Brief Summary
The purpose of this study is to observe the effect of autologous fat grafting on soft tissue reconstruction of the breast following radiation treatment. Moving fat from one part of the body to another has been used for reconstruction for hundreds of years. However, it is not fully understood how well this works in reconstruction after radiation is used for cancer treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedFirst Submitted
Initial submission to the registry
May 8, 2023
CompletedFirst Posted
Study publicly available on registry
June 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 23, 2026
April 1, 2026
2.8 years
May 8, 2023
April 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Skin Fibrometry before and after fat transfer in reconstruction.
Soft tissue assessment is made using a non-invasive device SkinFibrometer (Delfin Kuopio, Finland) that measures tissue edema and skin elasticity. Measurements will be taken in all four quadrants of the affected (radiated) breast or reconstructed breast before and after the grafting procedure.
12 months
Secondary Outcomes (2)
Change in Radiation Injury before and after fat transfer.
12 months
Change in patient reported satisfaction of the breast measure before and after fat transfer.
12 months
Eligibility Criteria
This study will enroll participants from the University of Chicago who are undergoing autologous fat grafting as part of their reconstruction for breast cancer.
You may qualify if:
- Able to give consent
- Undergoing elective autologous fat grafting
- Previously treated for breast cancer
- Previous treatment included radiation therapy to the breast/chest wall.
You may not qualify if:
- Unable to give consent
- No history of radiation to the breast or chest wall
- No prior treatment for breast cancer
- No indication for autologous fat grafting
- Currently pregnant or breastfeeding
- Currently consuming nicotine products (smoking, vaping, patches, gum)
- Under the age of 18
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Summer E Hanson
Chicago, Illinois, 60637, United States
Related Publications (2)
Pattani N, Sanghera J, Langridge BJ, Frommer ML, Abu-Hanna J, Butler P. Exploring the mechanisms behind autologous lipotransfer for radiation-induced fibrosis: A systematic review. PLoS One. 2024 Jan 25;19(1):e0292013. doi: 10.1371/journal.pone.0292013. eCollection 2024.
PMID: 38271326BACKGROUNDZheng M, Liu Z, He Y. Radiation-induced fibrosis: Mechanisms and therapeutic strategies from an immune microenvironment perspective. Immunology. 2024 Aug;172(4):533-546. doi: 10.1111/imm.13788. Epub 2024 Apr 1.
PMID: 38561001BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 8, 2023
First Posted
June 6, 2023
Study Start
March 1, 2023
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
April 23, 2026
Record last verified: 2026-04